Factors Affecting Performance on a Screening Tool in Persons with Amyotrophic Lateral Sclerosis

Abstract

Persons with amyotrophic lateral sclerosis (PALS) are at risk of developing cognitive impairments and frontotemporal dementia (FTD). This study examined the relationship between performance of the ALS-Cognitive Behavioral Screen (ALS-CBS) and the demographic parameters of sex, education, time post–ALS diagnosis, and severity of symptoms. Data were collected retrospectively from 69 participants seen at the Mayo Clinic. Correlations were conducted on the ALS-CBS total scores and subsection scores and the above listed parameters; t-tests were conducted between participant subgroups. No statistically significant relationships or differences occurred between the ALS-CBS or its subsections and the variables measured with exception of age and the attention subsection. Older participants had lower ALS-CBS attention subsection scores. Based on the ALS-CBS scores, most participants had some degree of cognitive impairments: 43 had suspected cognitive impairment, 8 had suspected FTD; 18 fell within the normal range of cognitive function. Overall, the variables of sex, education, time post-diagnosis, and severity of symptoms do not appear to influence ALS-CBS scores. It is recommended cognitive screenings be completed for all PALS due to the high risk for developing cognitive impairments and FTD. Such knowledge can help clinicians develop assessment and treatment plans.

Keywords

ALS - cognition - neurodegenerative - adults

Disclosures

Julie A. G. Stierwalt discloses that she is on the editorial board for Seminars in Speech and Language. The remaining authors declared that they have no financial or nonfinancial information to disclose.

Publication History

Article published online:
02 April 2024

• References

• Abrahams, S., Goldstein, L. H., Al-Chalabi, A., Pickering, A., Morris, R. G., Passingham, R. E., Brooks, D. J., & Leigh, P. N. (1997). Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 62(5), 464–472
• Aiello, E. N., Esposito, A., Giannone, I., Diana, L., Woolley, S., Murphy, J., Christodoulou, G., Tremolizzo, L., Bolognini, N., & Appollonio, I. (2022). ALS Cognitive Behavioral Screen-Phone Version (ALS-CBS™-PhV): norms, psychometrics, and diagnostics in an Italian population sample. Neurological Sciences, 43, 2571–2578
• Bock, M., Duong, Y. N., Kim, A., Allen, I., Murphy, J., & Lomen-Hoerth, C. (2017). Progression and effect of cognitive-behavioral changes in patients with amyotrophic lateral sclerosis. Neurology. Clinical Practice, 7(6), 488–498
• Branco, L. M. T., Zanao, T., De Rezende, T. J., Casseb, R. F., Balthazar, M. F., Woolley, S. C., & França, M. C., Jr. (2017). Transcultural validation of the ALS-CBS Cognitive Section for the Brazilian population. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 18, 60–67
• Brown, R. T., & Steinman, M. A. (2013). Characteristics of emergency department visits by older versus younger homeless adults in the United States. American Journal of Public Health, 103(6), 1046–1051
• Caga, J., Devenney, E., Huynh, W., Zoing, M. C., Ahmed, R. M., & Kiernan, M. C. (2021). Illness cognitions in ALS: new insights into clinical management of behavioural symptoms. Frontiers in Neurology, 12, 740693
• Caga, J., Hsieh, S., Lillo, P., Dudley, K., & Mioshi, E. (2019). The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Frontiers in Neurology, 10(192), 192
• Cedarbaum, J. M., & Stambler, N. (1997). Performance of the amyotrophic lateral sclerosis functional rating scale (ALSFRS) in multicenter clinical trials. Journal of the Neurological Sciences, 152(Suppl 1), S1–S9
• Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., Nakanishi, A., & the BDNF ALS Study Group (Phase III). (1999). The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. Journal of the Neurological Sciences, 169(1-2), 13–21
• Chiò, A., Moglia, C., Canosa, A., Manera, U., D'Ovidio, F., Vasta, R., Grassano, M., Brunetti, M., Barberis, M., Corrado, L., D'Alfonso, S., Iazzolino, B., Peotta, L., Sarnelli, M. F., Solara, V., Zucchetti, J. P., De Marchi, F., Mazzini, L., Mora, G., & Calvo, A. (2020). ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology, 94(8), e802–e810
• Chiò, A., Moglia, C., Canosa, A., Manera, U., Vasta, R., Brunetti, M., Barberis, M., Corrado, L., D'Alfonso, S., Bersano, E., Sarnelli, M. F., Solara, V., Zucchetti, J. P., Peotta, L., Iazzolino, B., Mazzini, L., Mora, G., & Calvo, A. (2019). Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology, 93(10), e984–e994
• Chiò, A., Vignola, A., Mastro, E., Giudici, A. D., Iazzolino, B., Calvo, A., Moglia, C., & Montuschi, A. (2010). Neurobehavioral symptoms in ALS are negatively related to caregivers' burden and quality of life. European Journal of Neurology, 17(10), 1298–1303
• Cohen, J. (1988). Statistical Power Analysis for the Behavioral sciences (2nd ed.). Lawrence Erlbaum Associates
• Consonni, M., Dalla Bella, E., Bersano, E., & Lauria, G. (2021). Cognitive and behavioural impairment in amyotrophic lateral sclerosis: a landmark of the disease? A mini review of longitudinal studies. Neuroscience Letters, 754, 135898
• Costello, E., Rooney, J., Pinto-Grau, M., Burke, T., Elamin, M., Bede, P., McMackin, R., Dukic, S., Vajda, A., Heverin, M., Hardiman, O., & Pender, N. (2021). Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study. Journal of Neurology, Neurosurgery, and Psychiatry, 92(5), 460–465
• De Marchi, F., Sarnelli, M. F., Solara, V., Bersano, E., Cantello, R., & Mazzini, L. (2019). Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica, 139, 438–445
• Elamin, M., Phukan, J., Bede, P., Jordan, N., Byrne, S., Pender, N., & Hardiman, O. (2011). Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology, 76(14), 1263–1269
• Ellis, C. (2009). Does race/ethnicity really matter in adult neurogenics? American Journal of Speech-Language Pathology, 18(4), 310–314
• Evers, K., Kilander, L., & Lindau, M. (2007). Insight in frontotemporal dementia: Conceptual analysis and empirical evaluation of the consensus criterion "loss of insight" in frontotemporal dementia. Brain and Cognition, 63(1), 13–23
• Fang, T., Al Khleifat, A., Meurgey, J.-H., Jones, A., Leigh, P. N., Bensimon, G., & Al-Chalabi, A. (2018). Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study. Lancet Neurology, 17(5), 416–422
• Fitzgerald, K. C., O'Reilly, E. J., Falcone, G. J., McCullough, M. L., Park, Y., Kolonel, L. N., & Ascherio, A. (2014). Dietary ?-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurology, 71, 1102–1110
• Folstein, M. F., Folstein, S. E., & Fanjiang, G. (2001). Mini-Mental State Examination: clinical guide. Psychological Assessment Resources
• Golden, C. J. (1976). Identification of brain disorders by the Stroop Color and Word Test. Journal of Clinical Psychology, 32, 654–658
• Gosselt, I. K., Nijboer, T. C. W., & Van Es, M. A. (2020). An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 21, 324–336
• Inouye, S. K., Westendorp, R. G. J., & Saczynski, J. S. (2014). Delirium in elderly people. Lancet, 383, 911–922
• Irwin, D., Lippa, C. F., & Swearer, J. M. (2007). Cognition and amyotrophic lateral sclerosis (ALS). American Journal of Alzheimer's Disease and Other Dementias, 22, 300–312
• Kallambettu, V., Burda, A. N., & Wakeman, N. (2017). South Asian adults' performance on executive function tests. American Journal of Speech-Language Pathology, 26(4), 1254–1261
• Kaplan, E. G., & Weintraub, S. (1983). Boston Naming Test. Lea and Febiger
• Kelkar, A. S., Hough, M. S., & Fang, X. (2013). Do we think alike? A cross-cultural study of executive functioning. Culture and Brain, 1, 118–137
• Kertesz, A. (1982). Western Aphasia Battery. The Psychological Corporation
• Khin Khin, E., Minor, D., Holloway, A., & Pelleg, A. (2015). Decisional capacity in amyotrophic lateral sclerosis. The Journal of the American Academy of Psychiatry and the Law, 43, 210–217
• Kiousi, V., Arnaoutoglou, M., & Printza, A. (2019). Speech and language intervention for language impairment in patients in the FTD-ALS spectrum. Hellenic Journal of Nuclear Medicine, 22(Suppl), 133–146
• Kramer, A. F., & Kray, J. (2006). Aging and attention. In: E. Bialystok & F. I. M. Craik (Eds.), Lifespan cognition: mechanisms of change (pp. 57–69). Oxford University Press
• Levey, S., Cheng, L-R., & Almodovar, D. (2020). Developing evidence-based assessment to prevent over- or underidentification of disorders for new language learners. Perspectives of the ASHA Special Interest Groups, 5(4), 1026–1038
• Levine, D. A., Gross, A. L., Briceño, E. M., Tilton, N., Giordani, B. J., Sussman, J. B., Hayward, R. A., Burke, J. F., Hingtgen, S., Elkind, M. S. V., Manly, J. J., Gottesman, R. F., Gaskin, D. J., Sidney, S., Sacco, R. L., Tom, S. E., Wright, C. B., Yaffe, K., & Galecki, A. T. (2021). Sex differences in cognitive decline among US adults. JAMA Network Open, 4(2), e210169
• Lomen-Hoerth, C., Murphy, J., Langmore, S., Kramer, J. H., Olney, R. K., & Miller, B. (2003). Are amyotrophic lateral sclerosis patients cognitively normal? Neurology, 60, 1094–1097
• Mahoney, J. R., Verghese, J., Goldin, Y., Lipton, R., & Holtzer, R. (2010). Alerting, orienting, and executive attention in older adults. Journal of the International Neuropsychological Society, 16(5), 877–889
• Masrori, P., & Van Damme, P. (2020). Amyotrophic lateral sclerosis: a clinical review. European Journal of Neurology, 27(10), 1918–1929
• Mayo Clinic. (2022, October 13). Amyotrophic lateral sclerosis (ALS). Accessed March 7, 2024 at: https://www.mayoclinic.org/diseases-conditions/amyotrophic-lateral-sclerosis/symptoms-causes/syc-20354022
• McMackin, R., Muthuraman, M., Groppa, S., Babiloni, C., Taylor, J.-P., Kiernan, M. C., Nasseroleslami, B., & Hardiman, O. (2019). Measuring network disruption in neurodegenerative diseases: new approaches using signal analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 90(9), 1011–1020
• Morley, J. E., & Tumosa, N. (2002). Saint Louis University Mental Status Examination (SLUMS). Aging Successfully, XII, 4
• Murphy, J., Factor-Litvak, P., Goetz, R., Lomen-Hoerth, C., Nagy, P. L., Hupf, J., Singleton, J., Woolley, S., Andrews, H., Heitzman, D., Bedlack, R. S., Katz, J. S., Barohn, R. J., Sorenson, E. J., Oskarsson, B., Fernandes Filho, J. A., Kasarskis, E. J., Mozaffar, T., Rollins, Y. D., . . . Mitsumoto, H., & the ALS COSMOS. (2016). Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology, 86(9), 813–820
• Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., Cummings, J. L., & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699
• Owen, A. M., Roberts, A. C., Hodges, J. R., Summers, B. A., Polkey, C. E., & Robbins, T. W. (1993). Contrasting mechanisms of impaired attentional set-shifting in patients with frontal lobe damage or Parkinson's disease. Brain, 116, 1159–1175
• Pagnini, F., Phillips, D., Haulman, A., Bankert, M., Simmons, Z., & Langer, E. (2022). An online non-meditative mindfulness intervention for people with ALS and their caregivers: a randomized controlled trial. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 23(1-2), 116–127
• Pape, J. A., & Grose, J. H. (2020). The effects of diet and sex in amyotrophic lateral sclerosis. Revue Neurologique, 176, 301–315
• Park, Y., Park, J., Kim, Y., Baek, H., & Kim, S. H. (2015). Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition (Burbank, Los Angeles County, Calif.), 31(11-12), 1362–1367
• Pender, N., Pinto-Grau, M., & Hardiman, O. (2020). Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Current Opinion in Neurology, 33, 649–654
• Perry, R. J., Watson, P., & Hodges, J. R. (2000). The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia, 38, 252–271
• Phukan, J., Pender, N. P., & Hardiman, O. (2007). Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurology, 6, 994–1003
• Pinkhardt, E. H., Jürgens, R., Becker, W., Mölle, M., Born, J., Ludolph, A. C., & Schreiber, H. (2008). Signs of impaired selective attention in patients with amyotrophic lateral sclerosis. Journal of Neurology, 255, 532–538
• Ratti, E., Domoto-Reilly, K., Caso, C., Murphy, A., Brickhouse, M., Hochberg, D., Makris, N., Cudkowicz, M. E., & Dickerson, B. C. (2021). Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD. Brain Imaging and Behavior, 15, 2540–2551
• Rechtman, L., Jordan, H., Wagner, L., Horton, D. K., & Kaye, W. (2015). Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 16, 65–71
• Ringholz, G. M., Appel, S. H., Bradshaw, M., Cooke, N. A., Mosnik, D. M., & Schulz, P. E. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology, 65(4), 586–590
• Rush, B. K. (2014). ALS, cognitive impairment and dementia: a professional's guide. Accessed March 7, 2024 at: https://www.als.org/navigating-als/resources/fyi-als-cognitive-impairment-dementia
• Scheffner Hammer, C. (2012). Do demographic and cultural differences exist in adulthood? American Journal of Speech-Language Pathology, 21(3), 181–182
• Stierwalt, J. D., Stierwalt, J. A. G., & Clark, H. M. (2016, October). The ALS Cognitive Behavioral Screen: Results from a cohort of 69 people with ALS (PALS). Poster session presented at the Annual Meeting of Iowa Speech-Language and Hearing Association, Iowa City, IA
• Tariq, S. H., Tumosa, N., Chibnall, J. T., Perry, M. H., III, & Morley, J. E. (2006). Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder – a pilot study. The American Journal of Geriatric Psychiatry, 14(11), 900–910
• Tomaszewski Farias, S., Schmitter-Edgecombe, M., Weakley, A., Harvey, D., Denny, K. G., Barba, C., Gravano, J. T., Giovannetti, T., & Willis, S. (2018). Compensation strategies in older adults: association with cognition and everyday function. American Journal of Alzheimer's Disease and Other Dementias, 33, 184–191
• Tremolizzo, L., Lizio, A., Santangelo, G., Diamanti, S., Lunetta, C., Gerardi, F., Messina, S., La Foresta, S., Riva, N., Falzone, Y., Filippi, M., Woolley, S. C., Sansone, V. A., Siciliano, M., Ferrarese, C., Appollonio, I., & the ALS-CBS Italian Study Group. (2020). ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability. Neurological Sciences, 41, 835–841
• Turon-Sans, J., Gascon-Bayarri, J., Reñé, R., Rico, I., Gámez, C., Paipa, A., & Povedano, M. (2016). Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 17, 221–227
• Veldink, J. H., Kalmijn, S., Groeneveld, G. J., Wunderink, W., Koster, A., de Vries, J. H., van der Luyt, J., Wokke, J. H. J., & Van den Berg, L. H. (2007). Intake of polyunsaturated fatty acids and vitamin E reduces the risk of developing amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry, 78, 367–371
• Wills, A. M., Hubbard, J., Macklin, E. A., Glass, J., Tandan, R., Simpson, E. P., Brooks, B., Gelinas, D., Mitsumoto, H., Mozaffar, T., Hanes, G. P., Ladha, S. S., Heiman-Patterson, T., Katz, J., Lou, J. S., Mahoney, K., Grasso, D., Lawson, R., Yu, H., Cudkowicz, M., & the MDA Clinical Research Network. (2014). Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet, 383, 2065–2072
• Woolley, S., Goetz, R., Factor-Litvak, P., Murphy, J., Hupf, J., Garofalo, D. C., Lomen-Hoerth, C., Andrews, H., Heitzman, D., Bedlack, R., Katz, J., Barohn, R., Sorenson, E., Oskarsson, B., Filho, A. F., Kasarskis, E., Mozaffar, T., Nations, S., Swenson, A., . . . Mitsumoto, H. (2018). Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behavioral Neurology, 2018, 5969137
• Woolley, S. C., & Strong, M. J. (2015). Frontotemporal dysfunction and dementia in amyotrophic lateral sclerosis. Neurology Clinical Practice Journal, 33(4), 787–805
• Woolley, S. C., York, M. K., Moore, D. H., Strutt, A. M., Murphy, J., Schulz, P. E., & Katz, J. S. (2010). Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotrophic Lateral Sclerosis; Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 11, 303–311
• Yang, T., Hou, Y., Li, C., Cao, B., Cheng, Y., Wei, Q., Zhang, L., & Shang, H. (2021). Risk factors for cognitive impairment in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Journal of Neurology, Neurosurgery, and Psychiatry, 92(7), 688–693
• Yorkston, K. M., Miller, R. M., Strand, E. A., & Britton, D. (2013). Management of speech and swallowing disorders (3rd ed.). Austin, TX: Pro-ed
• Zanto, T. P., & Gazzaley, A. (2014). Attention and ageing. In: K. Nobre and S. Kastner (Eds.), The Oxford Handbook of Attention (pp. 927–971). Oxford University Press